Literature DB >> 27835839

Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.

Joel E Mortensen1, Barbara DeBurger2, Eleanor A Powell2, Jeanna DiFranco-Fisher3, Laura Koeth3, Scott J Weissman4.   

Abstract

Although carbapenem-resistant Enterobacteriaceae (CRE) have been recognised worldwide, there are important gaps in regional prevalence data. This study sought to determine the occurrence and type of CRE in the Cincinnati tri-state region. Clinical microbiology laboratories in the region screened patient stool and rectal swab samples using chromogenic screening agar. Isolates of Enterobacteriaceae resistant to carbapenems were characterised using molecular methods. Area institutions screened 1939 patient samples. Of 18 Enterobacteriaceae that grew on the screening agar, 8 isolates were resistant to one or all carbapenems and 6 isolates (all Klebsiella spp.) tested positive for a blaKPC gene. This study provides guidance on the prevalence of KPC and the genetic characteristics of carbapenem-resistant Klebsiella pneumoniae isolates in the Cincinnati tri-state area. Additional similar local epidemiology studies are warranted to provide an understanding and control of the spread of CRE. Copyright Â
© 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRE; Carbapenem; Carbapenem-resistant Enterobacteriaceae; Carbapenemase; KPC

Mesh:

Substances:

Year:  2016        PMID: 27835839     DOI: 10.1016/j.jgar.2016.08.012

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  2 in total

1.  Susceptibility of Selected Multi-Drug Resistant Clinical Isolates to Leaves of Carpolobia lutea.

Authors:  Ibikunle Anibijuwon; Ifeoluwa Gbala; Jumai Abioye
Journal:  Ethiop J Health Sci       Date:  2018-03

2.  Potentials of Actinomycetes from Reserved Environments as Antibacterial Agents Against Drug-Resistant Clinical Bacterial Strains.

Authors:  Risikat Nike Ahmed; Folake Daniel; Ifeoluwa Deborah Gbala; Alhassan Sanni
Journal:  Ethiop J Health Sci       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.